Results 321 to 330 of about 564,426 (377)

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study. [PDF]

Blood Adv
Phillips EH, Counsell N, Illidge T, Andre M, Aurer I, Fiaccadori V, Fortpied C, Neven A, Federico M, Barrington SF, Raemaekers J, Radford J.   +11 more
europepmc   +1 more source

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun, Dan Huang, Huiling Zhang, Mingyuan Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li, Zhaogang Yang   +10 more
wiley   +1 more source

Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy. [PDF]

Oncol Res
Cheng Y, Shen Y, Zhang Y, Nuriding H, Wang X, Fan C, Maimaiti G, Liu YU, Yue Y, Li D, Yan M.   +10 more
europepmc   +1 more source

An innovative benefit‐of‐the‐doubt approach for health system effectiveness: a global case study on amenable mortality

International Transactions in Operational Research, Volume 32, Issue 5, Page 2847-2877, September 2025.
Abstract Health system performance assessment (HSPA) is essential for health planning and to improve population health. One of the HSPA domains is related to effectiveness, which can be represented considering different dimensions. Composite indicators can be used to summarize complex constructs involving several indicators. One example of such efforts
Giovanna D'Inverno, João Vasco Santos, Ana S. Camanho   +2 more
wiley   +1 more source

Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma. [PDF]

Hemasphere
Leivonen SK, Karihtala K, Pellinen T, Karjalainen-Lindsberg ML, Aoki T, Steidl C, Leppä S.   +6 more
europepmc   +1 more source

Comprehensive genetic and epigenetic characterization of Lynch‐like syndrome patients

International Journal of Cancer, Volume 157, Issue 4, Page 788-799, 15 August 2025.
What's new? Lynch‐like syndrome is associated with development of colorectal cancer (CRC) with microsatellite instability and loss of expression of certain mismatch repair (MMR) genes, similar to Lynch syndrome, but unlike Lynch syndrome, the genetic cause of Lynch‐like syndrome (LLS) remains unknown.
Francesca Pirini, Luciano Calzari, Gianluca Tedaldi, Michela Tebaldi, Valentina Zampiga, Ilaria Cangini, Rita Danesi, Mila Ravegnani, Valentina Arcangeli, Alessandro Passardi, Elisabetta Petracci, Sara Bravaccini, Giorgia Marisi, Alessandra Viel, Daniela Barana, Monica Pedroni, Luca Roncucci, Daniele Calistri, Davide Gentilini   +18 more
wiley   +1 more source

Targeting CD30L in B-cell non-Hodgkin lymphoma: novel peptide conjugates and their therapeutic potential. [PDF]

Mol Cancer
Shi C, Lan T, Gao Y, Liang Z, Zhang Y, Tu Y, Liu H, Tu Z.   +7 more
europepmc   +1 more source

PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma

American Journal of Hematology, Volume 100, Issue 8, Page 1295-1304, August 2025.
Extranodal marginal zone lymphoma (EMZL) is essentially an FDG‐avid disease. PET/CT improves the precision in the response assessment compared to contrast‐enhanced CT. ABSTRACT 18Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is the standard imaging modality in lymphoma.
Juan Pablo Alderuccio, Russ A. Kuker, Eduardo Edelman Saul, Michele D. Stanchina, Mark K. Polar, Jennifer Chapman, Wei Zhao, Rafael Hennemann Sassi, Craig H. Moskowitz, Isildinha M. Reis, Izidore S. Lossos   +10 more
wiley   +1 more source

Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphoma. [PDF]

Br J Haematol
Srinivasan S, Narayan A, Dhamne C, Chichra A, Khemani P, Dhariwal N, Ranjan R, Shah S, Shet T, Gollamudi VRM, Roy Moulik N, Banavali SD, Narula G.   +12 more
europepmc   +1 more source

Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes

American Journal of Hematology, Volume 100, Issue 8, Page 1397-1407, August 2025.
Mixed autoimmune hemolytic anemia (AIHA) is a rare condition characterized by the presence of both warm and cold autoantibodies, often leading to severe, treatment‐resistant hemolysis. In this systematic review of 81 patients across 35 studies, the median age was 45 years with a notable female predominance.
Jeremy W. Jacobs, Sheharyar Raza, Landon M. Clark, Laura D. Stephens, Elizabeth S. Allen, Jennifer S. Woo, Rachel Lane Walden, Cristina A. Figueroa Villalba, Christopher A. Tormey, Caroline G. Stanek, Brian D. Adkins, Evan M. Bloch, Garrett S. Booth   +12 more
wiley   +1 more source